Attached files

file filename
EX-99.1 - EARNINGS RELEASE DATED MARCH 6, 2012 - InspireMD, Inc.q1100402_ex99-1.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
_________________
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
_________________
 
Date of Report (Date of earliest event reported):  March 6, 2012
 
InspireMD, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
 
000-54335
 
26-2123838
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)

3 Menorat Hamaor St.
Tel Aviv, Israel
 
67448
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: 972-3-691-7691


(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 2.02
Results of Operations and Financial Condition.

On March 6, 2012, InspireMD, Inc. (the “Company”) issued a press release announcing financial results for the fiscal year ended December 31, 2011. A copy of such press release is furnished as Exhibit 99.1.

The information in this Current Report and the accompanying exhibits are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), and are not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference to this Current Report in such a filing.

Item 9.01 
Financial Statements and Exhibits.

(d)           Exhibits

Exhibit Number
 
Description
99.1
 
Earnings release dated March 6, 2012.
 
 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
INSPIREMD, INC.
 
       
Date: March 13, 2012
By:
/s/ Craig Shore
 
   
Name: Craig Shore
 
   
Title: Chief Financial Officer
 
       
 
 
 

 
 
EXHIBIT INDEX

Exhibit Number
 
Description
99.1
 
Earnings release dated March 6, 2012.